NERATINIB
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | NERATINIB |
| DrugBank ID | DB11828 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 19 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| transitional cell carcinoma | TxGNN Knowledge Graph | L5 |
| congestive heart failure | TxGNN Knowledge Graph | L5 |
| hypertension | TxGNN Knowledge Graph | L5 |
| hypertensive disorder | TxGNN Knowledge Graph | L5 |
| hiv infectious disease | TxGNN Knowledge Graph | L5 |
| aids | TxGNN Knowledge Graph | L5 |
| chronic hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| cystic fibrosis | TxGNN Knowledge Graph | L5 |
| bacterial arthritis | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11